1-15 of 314
Optimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableOptimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Alexandria May, PharmD, BCPS
Michael Czarnecki, MD
How to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableHow to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Brian P. McDonough, MD, FAAFP
Brooks Kuhn, MD, MAS
A Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Clinician's RoundtableA Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Brian P. McDonough, MD, FAAFP
MeiLan Han, MD, MS
Interpreting and Applying cGVHD Clinical Trial Data
Project Oncology®Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP
Christopher Graham, MD
Evaluating Port-Wine Capillary Malformations in Children
On the Frontlines of Pediatric Skin HealthEvaluating Port-Wine Capillary Malformations in Children
Kristen Kelly, MD
Alexandria May, PharmD, BCPS
Comprehensive Management of Pediatric Port-Wine Capillary Malformations
On the Frontlines of Pediatric Skin HealthComprehensive Management of Pediatric Port-Wine Capillary Malformations
Kristen Kelly, MD
Alexandria May, PharmD, BCPS
- advertisement
Helping Patients Understand GPP’s Unpredictable and Systemic Nature
DermConsultHelping Patients Understand GPP’s Unpredictable and Systemic Nature
Charles Turck, PharmD, BCPS, BCCCP
Andrew Dorizas, MD, FAAD, ASMS
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart MattersEarly Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
Ronald Witteles, MD
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CMEarly Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD
Valmiki Maharaj, MD
Recognizing and Managing Swelling in ATTR-CM
On the Frontlines of ATTR-CMRecognizing and Managing Swelling in ATTR-CM
Steve Jackson, PharmD
Kevin S. Shah, MD
Understanding Real-World Testing Patterns in ATTR-CM
On the Frontlines of ATTR-CMUnderstanding Real-World Testing Patterns in ATTR-CM
Steve Jackson, PharmD
Ronald Witteles, MD
- advertisement
Recognizing ATTR-CM in High-Risk Populations
On the Frontlines of ATTR-CMRecognizing ATTR-CM in High-Risk Populations
Steve Jackson, PharmD
Frederick Ruberg, MD
Multidisciplinary Coordination in TK2d Diagnosis and Management
NeuroFrontiersMultidisciplinary Coordination in TK2d Diagnosis and Management
Charles Turck, PharmD, BCPS, BCCCP
Zarazuela Zolkipli-Cunningham, MBChB, MRCP
Oscar H. (Hank) Mayer, MD
Navigating NTM Lung Disease: A Patient-Centered Approach
Clinician's RoundtableNavigating NTM Lung Disease: A Patient-Centered Approach
Charles Turck, PharmD, BCPS, BCCCP
Kenneth Olivier, MD, MPH
Shelby MacRae, MD
